Daily Management Review

Pfizer Lowers Its Top Profit Margin Following The Third Quarter’s Earnings


11/04/2016


The “average analyst” forecast of Pfizer’s earnings were missed by one percent per share.



The largest manufacturer of drugs in the U.S., Pfizer Inc., issued its “quarterly adjusted profit” which just fell a little short on standing up to the estimates of the analysts, while four cents were shaved off by the company from its “2016 earnings forecast” following the decision of putting an end to the plans of developing “cholesterol-lowering treatment”.
 
Putting aside the “special items”, Pfizer’s third quarter’s earning equals to sixty one percent per share, whereby the estimates made by the “average analyst” was missed by one percent, reports “Thomson Reuters I/B/E/S”. Ibrance is a treatment for breast cancer developed by Pfizer which brought in sale’s revenue of “$550 million”. However, it missed the “$576 million” forecast of consensus which was compiled by “Evercore ISI”.
 
On the other hand, the pain drug, Lyrica, generated sales amount of “$1.05 billion”, which too failed to meet the expectation of “$1.28 billion”, whereas the sale of “Prevnar vaccine” over shot the forecast of “$1.48 billion” and brought in “$1.54 billion”. Furthermore, Pfizer reported that it will abandon the development of “bococizumab”, a drug for lowering cholesterol, reason being cited as an “evolving treatment landscape”.
 
As a result, Pfizer brought down the top earning forecast margin of 2016 to “$2.43”, while it maintained the “lower end at $2.38”. Moreover, the company increased its “revenue forecast” from “$51 billion” to “$52 billion”, yet retained the upper limit at “$53 billion”. According to Reuters:
“Bococizumab, which belongs to a pricey new class of medicines called PCSK9 inhibitors, was always going to be late to the party, since two rival drugs hit the market last summer - Praluent, co-developed by Regeneron (REGN.O) and Sanofi SA (SASY.PA) and Repatha from Amgen Inc (AMGN.O)”.
 
 
 
 
References:
http://www.reuters.com/







Science & Technology

Europe overtakes US by number of patents for self-driving car technologies

Samsung introduces display technology for folding screens

How retailers use technologies to increase sales

Facebook releases videochat devices Portal and Portal Plus

Smartphone makers will pay for pre-installing Google apps‍

Five loudest data leaks

Airbus announces Moon exploration competition

Former Head Of Google China Thinks Funding In AI Should Be Doubled By US

Germany Introduces The First Ever Train To Run On 100% Hydrogen

Germany Plans On Cyber Security Research To End Reliance On U.S. Tech

World Politics

World & Politics

Brexit Negotiators Of Both Parties Close Down On Irish Border Text, Reports RTE

Bloomberg: Theresa May can face catastrophic defeat in parliament

New Asian Foreign Policy May Be Set By Congress After Democrats Taking Control Of House

Italy refuses to change draft budget

Italy is about to tighten its migration policy

Macron calls to create a pan-European army

Signals Of Mending Of US-China Emerge Before Anticipated G20 Meet

Moscovici: the European Commission may impose sanctions on Italy